Welcome to our dedicated page for LAM RESEARCH SEC filings (Ticker: LRCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on LAM RESEARCH's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into LAM RESEARCH's regulatory disclosures and financial reporting.
Lam Research chief legal officer Ava Harter reported stock awards and related tax withholdings. On 02/27/2026, she received grants of 7,106 shares of common stock and 8,685 market-based performance restricted stock units at $0.00 per share. The common stock units will vest in three equal installments on 02/27/2027, 02/27/2028, and 02/27/2029. The performance units may vest between 0% and 150% on 02/27/2029, based on Lam Research’s total shareholder return versus the PHLX Semiconductor Total Return Index from 02/02/2026 through 02/01/2029. To satisfy tax withholding obligations upon vesting of restricted stock units, 1,988 shares were withheld on 02/27/2026 and 3,199 shares were withheld on 03/27/2026, at a price of $233.89 per share, leaving 58,705.455 common shares directly owned after the March transaction. The reported holdings include shares underlying unvested restricted stock units.
LAM RESEARCH CORP Senior Vice President Neil J. Fernandes reported equity awards and related tax withholding transactions. He received 10,113 market-based performance restricted stock units and 8,274 shares of common stock on February 27, 2026 as grant or award acquisitions at no cash cost.
The time-based restricted stock units vest in three equal installments on February 27, 2027, 2028, and 2029. The market-based performance units can vest between 0% and 150% on February 27, 2029, depending on Lam Research’s total shareholder return versus the PHLX Semiconductor Total Return Index over the performance period from February 2, 2026 through February 1, 2029. Multiple entries labeled as code F show an aggregate disposition of common shares at $233.89 per share to satisfy tax withholding obligations upon vesting, and his directly held common stock position after these transactions was 83,951 shares, including shares subject to unvested restricted stock units.
LAM RESEARCH CORP President and CEO Timothy Archer reported equity compensation and related tax withholdings. He received a grant of 76,580 Market-based Performance Restricted Stock Units and 51,053 shares of common stock on 02/27/2026. The RSUs and performance units vest over time through 02/27/2029, while 134,624, 9,975, 8,111 and 19,584 common shares were automatically withheld at $233.89 per share to cover tax obligations as his restricted stock units vested.
LAM RESEARCH CORP Executive Vice President Patrick J. Lord reported multiple Form 4 transactions in common stock on 2026-02-27. Shares were automatically withheld at $233.89 per share to cover tax obligations upon vesting of restricted stock units. After these tax-withholding dispositions, he directly owned 98,848 common shares, which the disclosure states includes unvested restricted stock units.
Lam Research Corp executive Christina Correia, the company's CVP and Chief Accounting Officer, reported multiple equity-related transactions dated February 27, 2026. She was granted 1,362 Market-based Performance Restricted Stock Units, which will vest between 0% and 150% on February 27, 2029 based on Lam Research's total shareholder return performance.
She also acquired 3,180 shares of common stock and another 12,979 shares of common stock through restricted stock unit awards. These restricted stock units vest in three installments on February 27, 2027, February 27, 2028, and February 27, 2029, with one award vesting 25%, 25%, and 50% on those dates. Several additional transactions labeled code F represent shares of common stock automatically withheld at a price of $233.89 per share to cover tax withholding obligations upon vesting. After these transactions, Correia directly owned 58,589 shares of common stock, including shares subject to unvested restricted stock units.
LRCX filing dated 03/02/2026 reports proposed sales of common stock by Fidelity Brokerage Services LLC. The notice lists multiple lots totaling examples shown: 6,579, 10,423, and 23,327 shares to be sold.
The filing is a Form 144 notice of intended sale and does not specify transaction proceeds or execution timing.
Fidelity Brokerage Services LLC submitted a Rule 144 notice concerning 4,000 shares of common stock of LRCX. The excerpt lists two tranches of restricted stock vesting recorded as compensation: 03/01/2025 for 2,000 shares and 03/01/2026 for 2,000 shares, with an entry dated 03/02/2026.
Lam Research President and CEO Timothy Archer reported a bona fide gift of 7,080 shares of common stock on February 24, 2026. After this gift, he directly owned 1,196,859 shares, including shares subject to unvested restricted stock units. He also reported indirect holdings of 48,025.775 shares through a 401(k) and 5,670.061 shares through his spouse’s 401(k).
Lam Research Corporation director Eric Brandt reported selling common stock in two transactions. On February 6, 2026, he sold 17,000 shares at $220.95 per share and 18,000 shares at $230 per share.
After these sales, Brandt beneficially owned 253,705 shares of Lam Research common stock directly. This reported amount includes shares that are subject to unvested restricted stock units.
Research Corp director Anirudh Devgan reported receiving 1,141 shares of common stock on February 6, 2026 in a transaction coded “A” at a price of $0 per share, indicating an equity award. The reported amount includes shares subject to unvested restricted stock units.
Following this grant, Devgan beneficially owns 1,141 shares directly and 312 shares indirectly through a trust, reflecting his combined direct and indirect holdings in the company’s common stock.